ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
SynbiCITE is the name of a synthetic biology research center planned for Imperial College London. The center, announced recently by David Willetts, the U.K.’s minister for universities and science, will receive about $37 million in combined government and industry funding. SynbiCITE will house scientists from 19 academic institutions and 13 industrial partners, including the research arms of GlaxoSmithKline, Microsoft, and Shell. Its goal is to translate research breakthroughs into new products.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X